← Back
$CUE All transactions

Cue Biopharma, Inc.

A

$ Value

$0

Shares

70,000

Price

$0

Filed

Dec 5

Insider

Name

Sandercock Colin

Title

SVP, GENERAL COUNSEL

CIK

0001724870

Roles

Officer

Transaction Details

Transaction Date

2025-12-03

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

70,000

Footnotes

On July 24, 2024 the Reporting Person was granted an option with vesting subject to the satisfaction of performance-based vesting criteria. The performance-based vesting criteria for these shares was deemed satisfied or waived on September 26, 2025 and these shares underlying the option vested. | On July 24, 2024 the Reporting Person was granted an option with vesting subject to the satisfaction of performance-based vesting criteria. The performance-based vesting criteria for these shares was deemed satisfied or waived on December 3, 2025 and these shares underlying the option vested.

Filing Info

Accession No.

0001193125-25-310067

Form Type

4

Issuer CIK

0001645460

Sandercock Colin's History

Date Ticker Type Value
2026-04-09 CUE A $0
2025-12-03 CUE A $0
2025-09-26 CUE A $0

Other Insiders at CUE (90d)

Insider Bought Sold Last
Sandercock Colin
SVP, GENERAL COUNSEL
2026-04-09
Warren Lucinda
CHIEF BUSINESS OFFICER
2026-04-09
Baker Daniel G.
CHIEF DEVELOPMENT OFFICER
2026-04-09